Eli Lilly Backs Guidance
475153
Eli Lilly (LLY:NYSE - news - research) Thursday confirmed earnings guidance and updated its drug pipeline efforts. The Indianapolis-based company still expects EPS of 73 cents to 75 cents and $2.80 to $2.82
514951
Eli Lilly & Co  and Japan's Daiichi Sankyo Co Ltd  said on Friday they had asked U.S. regulators to approve prasugrel, a blood clot preventer that is the U.S. drug maker's most important experimental product.
609109
FRIDAY, Sept. 14 (HealthDay News) -- The Eli Lilly drug Evista (raloxifene) has been approved by the U.S. Food and Drug Administration to reduce the risk of invasive breast cancer among postmenopausal at high risk for the disease and among postmenopausal women with osteoporosis.
446718
The US Food and Drug Administration has approved Eli Lilly&#39;s Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor.
573112
Eli Lilly and Co.  on Thursday said its third-quarter earnings rose as growing demand for its medicines offset higher spending to market recently approved treatments.
763482
Investors are likely to question why Lilly is still fiddling with the dosage of prasugrel.
567241
Drug company Eli Lilly  has  encouraged primary care physicians to use Zyprexa, a powerful  drug for schizophrenia and bipolar disorder, in patients who  did not have either condition, the New York Times reported on  its Web site on Monday, citing internal Lilly marketing  materials.
461758
Eli Lilly and Co. LLY.N said  Thursday it plans to cut 575 jobs, or a little more than 2  percent of its U.S. workforce, in a move to streamline its  operations.
79075
Eli Lilly pushed Zyprexa, a drug for schizophrenia and bipolar disorder, as a treatment for older patients with dementia, according to marketing materials.
17137
Eli Lilly and Co. on Thursday is on track to meet its 2006 growth forecast of 8 percent to 12 percent, but projected slower profit growth for 2007 even though its revenues will grow at a faster pace next year.
491539
Eli Lilly and Co on Tuesday said U.S. regulators approved once-daily use of two low-dose forms of its Cialis anti-impotence drug, offering greater convenience for men expecting frequent sexual activity.
746418
Bowing to pressure from an Icos Corp.  shareholder, Eli Lilly and Co.  said on Monday it has increased its offer for the biotechnology company to $2.3 billion from an earlier bid of $2.1 billion.
624263
Eli Lilly and Co LLY.N said Friday  it added a warning to the label of its attention  deficit/hyperactivity disorder medicine, advising patients with  jaundice or a liver injury to stop taking the treatment.
164881
Eli Lilly and Co. (LLY.N: Quote, Profile, Research) said Thursday it plans to cut 575 jobs, or a little more than 2 percent of its US workforce, in a move to streamline its operations.
615212
Eli Lilly and Co. LLY.N on Thursday  said it expects earnings in 2005 to rise to between $3.05 and  $3.15 per share before special items as growing sales of newer  medicines more than offset disappointing sales of its  top-selling schizophrenia drug.
712690
Eli Lilly &amp; Co. said Thursday it expects 2005 earnings, excluding the impact of expensing stock options, to be in line with analysts&#39; views.
339894
Drugmaker Eli Lilly and Co. LLY.N on  Thursday said it will eliminate up to 575 U.S. positions,  representing 2 percent of its U.S. work force, in order to  streamline operations and reduce costs.